高级检索
庄耿刚, 张丽君. 奥洛他定治疗过敏性结膜炎的疗效及其对血清、泪液相关指标的影响[J]. 实用临床医药杂志, 2016, (5): 85-87. DOI: 10.7619/jcmp.201605026
引用本文: 庄耿刚, 张丽君. 奥洛他定治疗过敏性结膜炎的疗效及其对血清、泪液相关指标的影响[J]. 实用临床医药杂志, 2016, (5): 85-87. DOI: 10.7619/jcmp.201605026
shu
ZHUANG Genggang, ZHANG Lijun. Efficacy of olopatadine in treatment of patients with allergicconjunctivitis and its influence on the serum and tear related indexes[J]. Journal of Clinical Medicine in Practice, 2016, (5): 85-87. DOI: 10.7619/jcmp.201605026
Citation: ZHUANG Genggang, ZHANG Lijun. Efficacy of olopatadine in treatment of patients with allergicconjunctivitis and its influence on the serum and tear related indexes[J]. Journal of Clinical Medicine in Practice, 2016, (5): 85-87. DOI: 10.7619/jcmp.201605026
shu

奥洛他定治疗过敏性结膜炎的疗效及其对血清、泪液相关指标的影响

Efficacy of olopatadine in treatment of patients with allergicconjunctivitis and its influence on the serum and tear related indexes

    摘要
  • 摘要: 目的 探讨奥洛他定治疗过敏性结膜炎的疗效及其对血清、泪液相关指标的影响.方法 90例过敏性结膜炎患者随机分为对照组(色甘酸钠滴眼液)和观察组(奥洛他定滴眼液),比较2组患者治疗前及治疗后各项症状体征评分、血清及泪液ECP、HA、LTB4及IgE水平.结果 治疗后,观察组的各项症状体征评分及血清、泪液ECP、HA、LTB4及IgE水平均显著低于对照组(P＜0.05).结论 奥洛他定能有效改善过敏性结膜炎患者的症状体征及血清、泪液相关指标.

     

    • HTML全文
    • 参考文献(0)
    • 相关文章
    • 施引文献
  • 资源附件(0)

/

返回文章
返回